Study Group: Internal Medicine Physicians who Treat Primary Pulmonary Hypertension (EU)

Council Members in this Study Group: 32

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Hossein Ghofrani, Physician, JUSTUS-LIEBIG-UNIVERSITAET GIESSENHossein Ghofrani

Physician
JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Hossein Ardeschir (Ardi) Ghofrani, MD, is Lead physician of the Pulmonary Hypertension Centre at the University of Giessen Lung Center (UGLC), Germany. Prof. Ghofrani is a Reviewer for various high impact scientific journals including Lancet, AJRCCM,...

Robert Naeije

Professor and Chairman, Department of Physiology
CLINIQUE UNIVERSITAIRE DE BRUXELLES HOPITAL ERASME VZW
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Robert Naeije, MD, PhD, is Professor and Chairman of the Department of Physiology and Pathophysiology and Director of the Pulmonary Hypertension Clinic at Erasme University Hospital. Dr. Naeije's main area of expertise is pulmonary circulation. His basic...

Jean-Luc Vachiery

Director of the Pulmonary Vascular Diseases Clinic
CLINIQUE UNIVERSITAIRE DE BRUXELLES HOPITAL ERASME VZW
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Jean-Luc Vachiery, MD, FESC, is Professor of Cardiology and Director of the Pulmonary Vascular Diseases Unit at Hôpital Erasme (Clinique Universitaires De Bruxelles), a leading pulmonary arterial hypertension (PAH) centre in Brussels. Dr. Vachiery is...

2 event(s)
Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*
  • Government/Military Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Physician - Department Chair
  • Director
  • Physician - Resident
  • Professor

Related Study Groups

Study Group Name No. Members
Pulmonologists (EU) 258
Diabetologist Endocrinologists (Germany) 39
Physicians Who Implant Drug Coated Stents (EU) 30
Emergency Medicine Physicians (EU) 250
Cardiologists (EU) 881
Critical Care Physicians in Europe 186
Surgeons who specialize in Transplantation 199
CPAP Device Prescribers (EU) 12

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Internal Medicine Physicians who Treat Primary Pulmonary Hypertension (EU) Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

Teleconference: Remodulin for PAH - Injected, Inhaled, and Swallowed (10:00 AM EDT)

9/22/2011

Play Recording

Teleconference: Treatments for PAH - Impact of the Thelin Recall (16:00 GMT / 11:00 AM EST)

12/22/2010

Play Recording